Mainz Biomed B.V.
MYNZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,183 | $753,644 | $4,020,728 | $2,996,845 |
| - Cash | $6,236 | $7,071 | $17,142 | $8,728 |
| + Debt | $3,271 | $7,421 | $3,228 | $2,576 |
| Enterprise Value | $1,218 | $753,994 | $4,006,814 | $2,990,694 |
| Revenue | $894 | $895 | $530 | $577 |
| % Growth | -0.2% | 69% | -8.2% | – |
| Gross Profit | $575 | $510 | $182 | $178 |
| % Margin | 64.3% | 56.9% | 34.4% | 30.8% |
| EBITDA | -$19,558 | -$25,011 | -$25,718 | -$11,281 |
| % Margin | -2,187.8% | -2,793.1% | -4,853.6% | -1,953.9% |
| Net Income | -$21,651 | -$26,296 | -$26,453 | -$11,690 |
| % Margin | -2,421.8% | -2,936.5% | -4,992.2% | -2,024.8% |
| EPS Diluted | -22.36 | -1.62 | -1.87 | -1.67 |
| % Growth | -1,280.2% | 13.4% | -12% | – |
| Operating Cash Flow | -$17,090 | -$21,939 | -$14,770 | -$3,220 |
| Capital Expenditures | -$255 | -$1,899 | -$658 | -$17 |
| Free Cash Flow | -$17,345 | -$23,838 | -$15,428 | -$3,237 |